日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PD-1-based combinations before autologous transplant are associated with improved outcomes in classical Hodgkin lymphoma

自体移植前采用基于PD-1的联合疗法可改善经典型霍奇金淋巴瘤的预后。

Desai, Sanjal H; Moskowitz, Alison J; Merryman, Reid W; Shah, Harsh; Pederson, Levi D; Geyer, Susan M; Ganesan, Nivetha; Chang, Tiffany; Othman, Tamer; Falade, Ayo S; Shah, Gunjan L; Durani, Urshila; Sumransub, Nuttavut; Ng, Lay She; Baron, Kelsey; Ong, Shin Yeu; Yoon, Kevin; Ansell, Stephen M; Armand, Philippe; Iyengar, Siddharth; Micallef, Ivana; Stuver, Robert; Herrera, Alex F; Mei, Matthew

Window of opportunity evaluation of blood-brain barrier permeability heterogeneity within and across high-grade glioma patients

评估高级别胶质瘤患者血脑屏障通透性异质性的窗口期

Oh, Ju-Hee; Reed, Sarah K; Riviere-Cazaux, Cecile; Kim, Minjee; Mladek, Ann C; Illamola, Silvia M; Zhang, Wenjuan; Vaubel, Rachael A; Caron, Alissa; Regan, Michael S; Birnbaum, Angela K; Mohammad, Afroz; Zhang, Wenqiu; Dixon, Jesse G; Kaufmann, Timothy J; Hu, Leland S; Ma, Daniel J; Kizilbash, Sani; Agar, Nathalie Y R; Giannini, Caterina; Geyer, Susan M; Parney, Ian F; Galanis, Evanthia; Burns, Terry C; Elmquist, William F; Sarkaria, Jann N

Single-cell multiomics reveal divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response

单细胞多组学揭示了DNMT3A和TET2突变克隆性造血在炎症反应中的不同作用

Mohammed Ismail, Wazim; Fernandez, Jenna A; Binder, Moritz; Lasho, Terra L; Kim, Minsuk; Geyer, Susan M; Mazzone, Amelia; Finke, Christy M; Mangaonkar, Abhishek A; Lee, Jeong-Heon; Wang, Liguo; Kim, Kwan Hyun; Simon, Vernadette A; Rakhshan Rohakthar, Fariborz; Munankarmy, Amik; Byeon, Seul Kee; Schwager, Susan M; Harrington, Jonathan J; Snyder, Melissa R; Robertson, Keith D; Pandey, Akhilesh; Wieben, Eric D; Chia, Nicholas; Gaspar-Maia, Alexandre; Patnaik, Mrinal M

Ibrutinib added to standard conditioning and as maintenance therapy following autologous hematopoietic stem cell transplantation for relapsed or refractory activated-B-cell type Diffuse Large B-cell lymphoma: primary analysis of the US intergroup double-blind randomized phase III study Alliance A051301/BMT-CTN 1201

伊布替尼加入标准预处理方案,并作为自体造血干细胞移植后复发或难治性活化B细胞型弥漫性大B细胞淋巴瘤的维持治疗:美国多中心双盲随机III期研究Alliance A051301/BMT-CTN 1201的主要分析

Andreadis, Charalambos; Bobek, Olivia; Hsi, Eric D; Fenske, Timothy S; Stiff, Patrick J; Hill, Brian T; Geyer, Susan M; Horwitz, Mitchell; Khimani, Farhad; Little, Richard F; Dinner, Shira N; Friedberg, Jonathan W; Kahl, Brad S; Perales, Miguel-Angel; Devine, Steven M; Leonard, John P; Bartlett, Nancy L

Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101

原发性中枢神经系统淋巴瘤的清髓性巩固治疗与非清髓性巩固治疗:Alliance 51101 研究结果

Batchelor, Tracy T; Giri, Sharmila; Ruppert, Amy S; Geyer, Susan M; Smith, Scott E; Mohile, Nimish; Swinnen, Lode J; Friedberg, Jonathan W; Kahl, Brad S; Bartlett, Nancy L; Hsi, Eric D; Cheson, Bruce D; Wagner-Johnston, Nina; Nayak, Lakshmi; Leonard, John P; Rubenstein, James L

CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

CALGB 80802(联盟):索拉非尼联合或不联合多柔比星对晚期肝细胞癌患者丙型肝炎感染的影响

Abou-Alfa, Ghassan K; Geyer, Susan M; Nixon, Andrew B; Innocenti, Federico; Shi, Qian; Kumthekar, Priya; Jacobson, Sawyer; El Dika, Imane; Yaqubie, Amin; Lopez, Juan; Huang, Binhui; Tang, Yi-Wei; Wen, Yujia; Schwartz, Lawrence H; El-Khoueiry, Anthony B; Knox, Jennifer J; Rajdev, Lakshmi; Bertagnolli, Monica M; Meyerhardt, Jeffrey A; O'Reilly, Eileen M; Venook, Alan P

Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis

系统性轻链淀粉样变性患者的分级心脏反应标准

Muchtar, Eli; Dispenzieri, Angela; Wisniowski, Brendan; Palladini, Giovanni; Milani, Paolo; Merlini, Giampaolo; Schönland, Stefan; Veelken, Kaya; Hegenbart, Ute; Geyer, Susan M; Kumar, Shaji K; Kastritis, Efstathios; Dimopoulos, Meletios A; Liedtke, Michaela; Witteles, Ronald; Sanchorawala, Vaishali; Szalat, Raphael; Landau, Heather; Petrlik, Erica; Lentzsch, Suzanne; Coltoff, Alexander; Bladé, Joan; Cibeira, Maria Teresa; Cohen, Oliver; Foard, Darren; Wechalekar, Ashutosh; Gertz, Morie A

High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment

高胰岛素原/C肽比值可识别出处于2期1型糖尿病阶段且进展至临床诊断风险较高以及对替普利珠单抗治疗反应较差的个体。

Sims, Emily K; Geyer, Susan M; Long, S Alice; Herold, Kevan C

Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined Significance

髓母细胞上异常的CD13/HLA-DR表达模式可预测意义未明的克隆性血细胞减少症患者发生髓系肿瘤的风险

Jevremovic, Dragan; Nanaa, Ahmad; Geyer, Susan M; Timm, Michael; Azouz, Haya; Hengel, Cynthia; Reberg, Alexander; He, Rong; Viswanatha, David; Salama, Mohamad E; Shi, Min; Olteanu, Horatiu; Horna, Pedro; Otteson, Gregory; Greipp, Patricia T; Xie, Zhuoer; Alkhateeb, Hassan B; Hogan, William; Litzow, Mark; Patnaik, Mrinal M; Shah, Mithun; Al-Kali, Aref; Nguyen, Phuong L

Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals

Teplizumab 可改善并稳定抗体阳性高危人群的β细胞功能

Sims, Emily K; Bundy, Brian N; Stier, Kenneth; Serti, Elisavet; Lim, Noha; Long, S Alice; Geyer, Susan M; Moran, Antoinette; Greenbaum, Carla J; Evans-Molina, Carmella; Herold, Kevan C